PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study

MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa,... Read more

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases

MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The study will leverage PacBio’s HiFi... Read more

Innovative Approach Redefines Data Analysis in Proteomics Research

Thermo Fisher Scientific and MSAID continue their collaboration to deliver transformative deep learning tools for proteomics data analysis PHILADELPHIA, Nov. 1, 2021 /PRNewswire/ — ASMS 2021 – Thermo Fisher Scientific, the world leader in serving science, and MSAID, the leader in proteomics artificial intelligence, have collaborated to provide proteomics researchers with advanced mass spectrometry software that generates... Read more

PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams

Secure, SaaS informatics platform drives streamlined workflows and accelerated decision-making for pharmaceutical and industrial customers   WALTHAM, Mass. – October 25, 2021– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Signals Research™ Suite , a full cloud based solution, deployed on Amazon Web Services. The... Read more

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain... Read more